BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11574732)

  • 1. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis.
    Nemoto H; Nakamoto H; Okada H; Sugahara S; Moriwaki K; Arai M; Kanno Y; Suzuki H
    Blood Purif; 2001; 19(4):361-8; discussion 368-9. PubMed ID: 11574732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury.
    Suyama H; Kawasaki Y; Morikawa S; Kaneko K; Yamanoue T
    Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K; Kubo K; Yoshikawa S; Koizumi T; Yasuo M; Furuya S; Hora K
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis.
    Kohro S; Imaizumi H; Yamakage M; Masuda Y; Namiki A; Asai Y; Maruyama I
    J Anesth; 2006; 20(1):11-6. PubMed ID: 16421670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
    Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
    Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect over time of endotoxin adsorption therapy in sepsis.
    Ueno T; Sugino M; Nemoto H; Shoji H; Kakita A; Watanabe M
    Ther Apher Dial; 2005 Apr; 9(2):128-36. PubMed ID: 15828924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
    Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
    J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure.
    Suzuki H; Nemoto H; Nakamoto H; Okada H; Sugahara S; Kanno Y; Moriwaki K
    Ther Apher; 2002 Jun; 6(3):234-40. PubMed ID: 12109950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Kobayashi N; Koide H
    Blood Purif; 2005; 23(6):417-20. PubMed ID: 16141713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.